ANGION BIOMEDICA CORP (ANGN) Stock News

NASDAQ:ANGN - Nasdaq - US03476J1079 - Common Stock - Currency: USD

1 +0.02 (+2.04%)

After market: 0.9437 -0.06 (-5.63%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ANGN Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Angion Biomedica Corp.

Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split

2 years ago - By: Benzinga - Mentions: GPCR VSTM TLRY ELEV ...

Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

2 years ago - By: Benzinga - Mentions: ONCR IFBD EFTR MRVL ...

Why Gap Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

2 years ago - By: Halper Sadeh LLC

ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders

3 years ago - By: Kahn Swick & Foti, LLC

ANGION BIOMEDICA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Angion Biomedica Corp - ANGN

3 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Angion Biomedica Corp. has entered into a Fair Transaction with Elicio

3 years ago - By: InvestorPlace - Mentions: CYAD CLXT MGOL BTBT ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

3 years ago - By: Halper Sadeh LLC

ANGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Angion Biomedica Corp. Is Fair to Shareholders

3 years ago - By: Angion Biomedica Corp.

Elicio Therapeutics and Angion Enter into Definitive Merger Agreement

3 years ago - By: Angion Biomedica Corp.

Angion Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

3 years ago - By: Angion Biomedica Corp.

Angion Provides Corporate Update and Reports Second Quarter 2022 Financial Results